ArticleJournal of lipid research2026
Prohibitin-1 cysteine-69 plays a sex-dependent role in fatty acid metabolism.
Article in Journal of lipid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic diseases are caused by dysregulation of glucose and lipid homeostasis, which relies on the function of adipose tissues (ATs). This regulation and the associated pathologies differ between sexes, which remain incompletely understood. Prohibitin-1 (PHB1) has multifaceted tissue-specific functions converging on metabolism. Here, we investigated the role of PHB1's evolutionarily conserved cysteine-69 by replacing it with an alanine in a knock-in (Phb1-KI) mouse model. We show that Phb1-KI mice lack cell surface localization of PHB1 and display sex-biased AT alterations in relative sizes of visceral and subcutaneous depots and their adipocyte sizes, expression of lipid metabolism effectors, and adipokine secretion. Phb1-KI adipocytes are defective in long-chain fatty acid uptake and mobilization, and their mitochondrial abnormalities and reduced oxidative capacity result in defective lipid metabolism. In compensation, Phb1-KI have increased glycolysis and Phb1-KI mice display improved glucose disposal and increased insulin sensitivity. Attributes of this phenotype manifested differently in males and females of Phb1-KI mice. Our results demonstrate the importance of cysteine-69 in sex-related function of PHB1 in integrative physiology and systemic metabolism.
Indexed as
Identifiers
42778065What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.